Coumaphos for Bees: CheckMite+ Safety, Resistance & Residue Concerns

This information is for educational purposes only. Never give your pet any medication without your veterinarian's guidance. Dosing, frequency, and safety depend on your pet's specific health profile.

Coumaphos is an organophosphate acaricide used in honey bee colonies under the brand name CheckMite+ Bee Hive Pest Control Strip. In the United States, EPA lists CheckMite+ as a registered product for Varroa mite control, and the same label also includes use against small hive beetles. It is considered a restricted-use pesticide, so handling and use need to follow label and state rules closely.

This medication works by affecting the nervous system of target parasites. In practice, it is placed inside the hive as impregnated strips so mites or beetles contact the active ingredient over time. While coumaphos remains federally registered, many bee health programs now discuss it more cautiously because Varroa resistance has been reported and because residues can persist in beeswax.

That means coumaphos is not a routine first choice for every colony. For some operations, it may still be part of a broader integrated pest management plan. For others, your vet or apiary advisor may steer you toward alternatives with lower residue concerns or better local effectiveness.

Coumaphos is labeled for two main hive pests: Varroa destructor mites and small hive beetles. Varroa mites are the bigger day-to-day concern in most apiaries because they weaken adult bees, damage brood, and spread viruses. Small hive beetles can also stress colonies, especially in warm climates or weaker hives.

Historically, CheckMite+ was an important in-hive option when synthetic strip treatments were widely used. Today, its role is more selective. EPA still lists it among registered Varroa products, but extension guidance and veterinary references note that resistance has reduced reliability in some areas. Because of that, treatment choice should be based on current mite counts, local resistance patterns, season, honey flow, and the condition of the colony.

Coumaphos is usually considered when a beekeeper needs a labeled in-hive pesticide option and has a clear reason to use it. It is not a preventive supplement and should not be used casually. Your vet can help decide whether it still makes sense for your colonies or whether rotation to another active ingredient would be safer and more effective.

For Varroa treatment, the CheckMite+ label directs beekeepers to remove honey supers before application and use one strip for each five combs of bees in each brood chamber. Strips are hung in separate spaces near the center of the brood cluster. If the colony uses two deep brood chambers, strips are placed in both the top and bottom brood chambers. The label says to leave strips in place for at least 42 days (6 weeks) but no more than 45 days, and not to treat more than twice per year for Varroa.

For small hive beetle treatment, the label directs removal of honey supers before application, then placement of one strip cut in half and attached to corrugated material or similar placement media on the bottom board near the center. As with Varroa treatment, the label calls for 42 to 45 days of exposure, with a maximum of four treatments per year for small hive beetle.

Exact timing matters. Treatment is generally most effective when brood rearing is lower, and label directions should be followed exactly. Because coumaphos is a restricted-use pesticide with food-residue implications, your vet and local apiary program should guide any use, especially if honey harvest, wax recycling, queen production, or repeated prior treatments are part of the picture.

The biggest practical concerns with coumaphos in bees are treatment failure from resistance, residue buildup in beeswax, and possible colony stress if it is overused or used in the wrong setting. Merck notes that coumaphos is still approved for honey bees but is no longer recommended in many situations because of resistance and accumulation in beeswax.

For the colony, warning signs after any in-hive pesticide use can include unusual adult bee mortality, poor brood pattern, reduced queen performance, or a colony that seems weaker after treatment rather than stronger. These signs are not specific to coumaphos alone, but they should prompt a review of diagnosis, application method, timing, ventilation, temperature conditions, and whether the colony was already under heavy parasite or virus pressure.

For people handling the product, the label warns that coumaphos can be harmful if absorbed through skin, can cause moderate eye irritation, and may trigger allergic skin reactions in some individuals. Protective gloves and careful handling are important. If your colony seems to decline during treatment, or if you suspect accidental overexposure, contact your vet, your state apiarist, or poison control right away.

In bee medicine, “drug interactions” often show up as stacked pesticide exposure rather than the classic medication interactions seen in dogs or cats. Coumaphos may be more concerning when colonies already carry residues from other miticides in wax, especially synthetic products used repeatedly over time. Extension and residue studies have raised concern that beeswax can act like a reservoir, meaning old treatments may still matter months or even seasons later.

That is one reason many bee health programs recommend rotating active ingredients instead of leaning on the same chemistry year after year. EPA specifically notes that rotation is an important tactic to slow resistance development in Varroa. If coumaphos is used after repeated prior exposure to coumaphos or other synthetic miticides, the tradeoff may be lower efficacy and higher residue burden.

Before using coumaphos, your vet can help review what else has been used in the hive, including amitraz, fluvalinate, formic acid, oxalic acid, thymol, or beetle-control products. The goal is not to avoid all combinations forever. It is to build a treatment plan that matches the season, honey production goals, wax management, and the colony's actual parasite pressure.